scanX
Laurus Labs
add_icon

Laurus Labs

1,507.40
+38.20
(2.60%)
Market Cap
81,377.98 Cr
PE Ratio
89.18
Volume
20,35,031.00
Day High - Low
1,524.60 - 1,460.00
52W High-Low
1,555.00 - 761.20
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
81,377.98 Cr
EPS
16.47
PE Ratio
89.18
PB Ratio
14.98
Book Value
98.11
EBITDA
1,832.70
Dividend Yield
0.14 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
16.38
Debt to Equity
0.54
Analyst Rating and Forecast
- By Refinitiv from13 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+38.46 %
+38.46 %
Hold
Hold+23.08 %
+23.08 %
Sell
Sell+38.46 %
+38.46 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Laurus Labs director tenure ends2 days ago
Mrs. Aruna Bhinge's tenure as Independent Director at Laurus Labs concluded on July 6, 2026, after her second term.
neutral
Laurus Labs Block Trade: ₹31.49 Cr Deal on NSE6 days ago
Laurus Labs sees a block trade of ~2,05,997 shares on NSE, valued at ₹31.49 crores at a price of ₹1528.70 per share.
positive
Laurus Labs approves dividends, appoints directors6 days ago
Shareholders ratified interim dividends of ₹0.80 and ₹1.20 per share for FY26. Dr. Shekhar Chintamani Mande and Ms. Sutapa Banerjee were appointed as Independent Directors.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,938.70
#1 4,65,159.07
39.36
#1 61,673.90
12.69
#1 11,565
25.80
70.46
Divis Laboratories
6,813.00
1,80,863.74
69.85
10,560.00
8.73
2,520
13.44
56.74
Torrent Pharmaceuticals
4,898.20
1,65,777.35
77.04
13,886.20
20.34
2,138
-26.91
75.89
Zydus Life Science
1,159.00
1,16,622.52
22.37
26,719.70
13.65
5,242
7.82
69.26
Cipla
1,441.30
1,16,434.75
29.95
29,044.60
2.24
3,870
-55.32
56.94
Lupin
2,503.30
1,14,459.02
#1 20.98
27,487.50
19.98
5,345
#1 87.72
70.07
Dr Reddys Laboratories
1,269.50
1,05,961.24
27.08
35,058.60
3.90
4,158
-86.05
39.41
Mankind Pharma
2,532.00
1,04,570.58
53.04
14,277.60
12.03
1,750
31.75
59.01
Aurobindo Pharma
1,587.40
91,335.49
25.81
33,384.70
3.21
3,376
1.99
61.30
Laurus Labs
1,507.40
#10 81,377.98
#10 89.18
#10 6,867.80
#1 22.01
#10 890
#4 21.18
61.14
Growth Rate
Revenue Growth
22.01 %
Net Income Growth
151.10 %
Cash Flow Change
169.84 %
ROE
112.73 %
ROCE
62.83 %
EBITDA Margin (Avg.)
32.87 %

Quarterly Financial Results

Quarterly Financials
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
412
525
519
483
486
545
489
565
542
599
531
637
555
714
732
841
981
1,144
1,295
1,417
1,284
1,206
1,034
1,426
1,541
1,577
1,546
1,383
1,185
1,226
1,197
1,458
1,197
1,228
1,425
1,779
1,580
1,680
1,784
1,823
Expenses
325
408
406
358
382
426
392
443
459
513
442
523
467
575
581
647
696
765
862
940
883
858
744
1,028
1,085
1,127
1,141
1,095
1,015
1,037
1,014
1,198
1,024
1,045
1,130
1,300
1,187
1,250
1,298
1,300
EBITDA
87
116
112
125
104
119
97
122
83
86
89
114
88
139
150
194
285
379
433
477
401
348
291
398
456
450
405
287
170
190
184
260
174
183
295
479
393
430
486
524
Operating Profit %
21 %
21 %
20 %
24 %
20 %
21 %
18 %
21 %
15 %
13 %
17 %
18 %
15 %
19 %
20 %
23 %
29 %
33 %
33 %
33 %
31 %
29 %
28 %
28 %
30 %
28 %
26 %
21 %
14 %
15 %
15 %
17 %
14 %
15 %
20 %
24 %
24 %
24 %
27 %
28 %
Depreciation
25
26
27
28
30
30
31
35
38
40
43
44
46
48
48
46
49
51
52
54
59
63
64
66
71
82
84
87
91
93
98
102
106
108
106
110
117
121
121
122
Interest
28
25
31
17
19
20
18
23
22
25
24
18
23
26
21
21
15
14
17
22
27
22
23
31
29
40
43
53
39
42
51
51
49
53
58
56
52
40
39
40
Profit Before Tax
35
66
54
81
55
70
49
64
23
22
23
53
19
66
82
127
222
314
364
401
316
263
204
302
356
328
278
147
41
54
35
107
19
23
131
312
224
270
327
361
Tax
9
18
9
9
16
21
14
19
6
6
5
9
4
9
8
17
50
72
91
104
74
59
49
70
104
95
75
42
14
17
11
32
6
3
38
80
63
75
75
79
Net Profit
26
48
45
71
39
49
35
45
17
16
18
43
15
57
74
110
172
242
273
297
242
204
155
232
252
233
203
105
27
37
23
75
13
20
93
233
162
195
252
282
EPS in ₹
3.73
5.18
4.50
6.75
3.68
4.61
3.29
4.26
1.56
1.53
1.67
4.07
1.42
1.06
1.38
2.06
3.21
4.53
5.09
5.53
4.50
3.76
2.87
4.29
4.68
4.33
3.78
1.90
0.46
0.69
0.43
1.40
0.23
0.37
1.71
4.34
3.02
3.61
4.67
5.17
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
1,894
2,224
2,653
3,017
3,331
3,750
5,751
6,968
7,660
8,387
9,336
10,511
Fixed Assets
801
1,021
1,230
1,481
1,629
1,726
2,171
2,653
3,409
3,890
4,123
4,371
Current Assets
865
1,003
1,140
1,248
1,463
1,812
3,075
3,345
3,462
3,835
4,332
4,829
Capital Work in Progress
110
70
143
163
110
67
362
813
551
423
458
773
Investments
0
7
3
3
3
3
3
31
50
124
233
309
Other Assets
983
1,126
1,277
1,369
1,589
1,953
3,215
3,472
3,651
3,950
4,521
5,058
Total Equity & Liabilities
1,894
2,224
2,653
3,017
3,331
3,750
5,751
6,968
7,660
8,387
9,336
10,511
Current Liabilities
805
884
1,121
1,307
1,424
1,692
2,457
2,681
2,432
3,112
3,540
3,635
Non Current Liabilities
365
483
202
227
349
288
693
928
1,180
1,159
1,193
1,444
Total Equity
724
857
1,330
1,483
1,558
1,770
2,601
3,359
4,049
4,116
4,603
5,431
Reserve & Surplus
642
774
1,225
1,371
1,447
1,658
2,490
3,244
3,930
4,003
4,365
5,192
Share Capital
82
82
106
106
106
107
107
108
108
108
108
108
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
24
-27
-10
1
0
-1
47
27
-30
93
-39
13
Investing Activities
-397
-312
-289
-384
-253
-221
-941
-915
-997
-822
-680
-1,086
Operating Activities
-65
182
332
343
298
347
733
911
994
666
602
1,624
Financing Activities
486
103
-54
42
-45
-128
255
30
-27
250
39
-525
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
27.45 %
27.30 %
27.30 %
27.27 %
27.27 %
27.27 %
27.27 %
27.20 %
27.20 %
27.20 %
27.20 %
27.19 %
27.19 %
27.18 %
27.18 %
27.62 %
27.62 %
27.59 %
27.59 %
27.49 %
27.49 %
FIIs
0.00 %
0.04 %
0.04 %
0.02 %
0.02 %
0.02 %
0.00 %
0.02 %
0.02 %
0.00 %
0.00 %
0.00 %
25.97 %
25.67 %
26.08 %
25.56 %
25.52 %
25.70 %
26.16 %
26.52 %
25.82 %
DIIs
2.06 %
2.40 %
2.11 %
2.77 %
3.51 %
4.77 %
8.98 %
9.51 %
9.74 %
10.14 %
10.71 %
10.77 %
11.77 %
13.56 %
13.05 %
12.74 %
11.77 %
11.94 %
11.73 %
12.43 %
13.97 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
34.17 %
34.18 %
32.91 %
32.87 %
31.15 %
28.42 %
27.96 %
28.95 %
28.49 %
28.26 %
26.49 %
25.01 %
23.95 %
22.68 %
22.67 %
22.72 %
23.65 %
23.12 %
23.33 %
22.64 %
21.24 %
Others
36.32 %
36.07 %
37.65 %
37.08 %
38.05 %
39.53 %
35.80 %
34.32 %
34.55 %
34.39 %
35.60 %
37.03 %
11.12 %
10.91 %
11.03 %
11.36 %
11.44 %
11.65 %
11.18 %
10.92 %
11.47 %
No of Share Holders
2,35,836
2,99,257
3,94,053
4,67,419
4,27,465
4,07,186
3,90,695
4,23,931
4,18,615
4,17,977
4,02,640
3,82,880
3,56,830
3,24,059
3,09,063
2,92,214
2,92,905
2,80,223
2,83,678
2,80,756
2,92,281

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1.5 1.5 1.5 2.5 2 2 2 0.8 1.2 2
Dividend Yield (%) 1.49 1.88 2.31 0.69 0.34 0.67 0.51 0.13 0.12 0.14

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
09 Feb 2021 DIVIDEND Dividend
₹ 0.40 /share
 08 Feb 2021 366.20 356.95
12 May 2021 DIVIDEND Dividend
₹ 0.80 /share
 11 May 2021 474.45 491.75
18 Nov 2021 DIVIDEND Dividend
₹ 0.80 /share
 17 Nov 2021 574.90 484.00
11 May 2022 DIVIDEND Dividend
₹ 1.20 /share
 10 May 2022 578.80 525.10
04 Nov 2022 DIVIDEND Dividend
₹ 0.80 /share
 03 Nov 2022 526.20 477.75
10 May 2023 DIVIDEND Dividend
₹ 1.20 /share
 10 May 2023 300.05 334.30
02 Nov 2023 DIVIDEND Dividend
₹ 0.40 /share
 02 Nov 2023 396.40 358.90
08 May 2024 DIVIDEND Dividend
₹ 0.40 /share
 08 May 2024 434.40 429.45
11 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 11 Jul 2024 434.40 472.50
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Oct 2024 480.30 449.35
06 Nov 2024 DIVIDEND Dividend
₹ 0.40 /share
 06 Nov 2024 449.35 489.25
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Jan 2025 611.75 585.15
24 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Apr 2025 564.25 650.45
09 May 2025 DIVIDEND Dividend
₹ 0.80 /share
 09 May 2025 650.45 586.00
26 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 26 Jun 2025 606.00 669.75
25 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 25 Jul 2025 778.30 836.50
23 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Oct 2025 858.25 923.90
31 Oct 2025 DIVIDEND Dividend
₹ 0.80 /share
 31 Oct 2025 923.90 970.35
23 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Jan 2026 1,100.90 1,004.95
30 Apr 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Apr 2026 1,082.85 1,105.70
08 May 2026 DIVIDEND Dividend
₹ 1.20 /share
 08 May 2026 1,105.70 1,206.50
02 Jul 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 02 Jul 2026 1,105.70 1,493.60

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 hr ago
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30 20261 hr ago
Completion Of Tenure Of Independent Director2 days ago
Announcement under Regulation 30 (LODR)-Credit Rating6 days ago
Appointment Of Independent Directors At The 21St Annual General Meeting Of The Company6 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report6 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM6 days ago
Closure of Trading Window9 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Letter To Shareholders Regarding Annual ReportJun 08, 2026
Business Responsibility and Sustainability Reporting (BRSR)Jun 08, 2026
Reg. 34 (1) Annual Report.Jun 08, 2026
Notice Of The 21St Annual General Meeting For The Financial Year 2025-26Jun 08, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 05, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2026
Inclusion Of Laurus Labs In Dow Jones Best-In-Class (DJ BIC) IndicesMay 21, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 02, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 30, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 30, 2026
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations 2015Apr 30, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations 2015Apr 30, 2026
Announcement under Regulation 30 (LODR)-AcquisitionApr 30, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 30, 2026
Corporate Action-Board approves DividendApr 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 30, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationApr 30, 2026
Disclosure under Regulation 30A of LODRApr 30, 2026
Board Meeting Outcome for Outcome Of The Board MeetingApr 30, 2026
Results - Financial Results March 31 2026Apr 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 09, 2026
Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Year Ended March 31 2026 And Payment Of 2Nd Interim Dividend For FY 2025-26Apr 09, 2026
Update On Meetings Of Unsecured Creditors In Relation To The Composite Scheme Of ArrangementApr 07, 2026
Closure of Trading WindowMar 30, 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMar 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 06, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 24, 2026
Laurus Labs Recognized For Sustainability Leadership By S&P GlobalFeb 23, 2026
Intimation Of ESG Score Given By SES ESG Research Private LimitedFeb 20, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 28, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Kotak Active Momentum Fund Direct-Growth
0.00%
-489241
-4.50%
-3.90%
HDFC Innovation Fund Direct-Growth
0.00%
-347343
-1.77%
-2.09%
JioBlackRock Flexi Cap Fund Direct-Growth
0.00%
-231542
-1.02%
-0.88%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
-230000
-5.76%
-4.78%
Bandhan Multi-Factor Fund Direct-Growth
0.00%
-192837
-3.87%
0.00%
TRUSTMF Multi Cap Fund Direct-Growth
0.00%
-81316
-2.10%
-1.59%
The Wealth Company Arbitrage Fund Direct-Growth
0.00%
-34850
-3.23%
-0.61%
TRUSTMF Mid Cap Fund Direct-Growth
0.00%
-33865
-1.91%
-1.67%
Samco Large & Mid Cap Fund Direct-Growth
0.00%
-32680
-3.73%
-2.12%
Tata Nifty Midcap 150 Index Fund Direct-Growth
0.00%
-27922
-1.31%
-1.10%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.00%
-25101
-1.32%
-1.09%
JioBlackRock Arbitrage Fund Direct-Growth
0.00%
-24650
-0.63%
-0.53%
Samco Mid Cap Fund Direct-Growth
0.00%
-20275
-3.64%
-3.05%
Groww Multi Asset Allocation Fund Direct-Growth
0.00%
-18508
-0.62%
-0.64%
Aditya Birla Sun Life BSE 500 Momentum 50 Index Fund Direct-Growth
0.00%
-16706
-3.24%
-2.67%
Unifi Dynamic Asset Allocation Fund Direct-Growth
0.00%
-13600
-0.15%
-0.13%
ITI Business Cycle Fund Direct-Growth
0.00%
-10608
-1.34%
-1.45%
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct-Growth
0.00%
-9341
-3.70%
-3.02%
Kotak Nifty Alpha 50 Index Fund Direct-Growth
0.00%
-8154
-3.33%
-2.79%
DSP Nifty Healthcare Index Fund Direct-Growth
0.00%
-7595
-5.08%
-4.24%
Kotak Nifty500 Momentum 50 Index Fund Direct-Growth
0.00%
-5208
-3.05%
-2.54%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-4334
-0.39%
-0.30%
Nippon India Nifty India Manufacturing Index Fund Direct-Growth
0.00%
-3697
-1.33%
-1.11%
Kotak Nifty Midcap 150 Index Fund Direct-Growth
0.00%
-3378
-1.31%
-1.11%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.00%
-1539
-0.48%
-0.39%

Technical Indicators

RSI(14)
Neutral
55.97
ATR(14)
Volatile
43.48
STOCH(9,6)
Neutral
67.70
STOCH RSI(14)
Neutral
29.01
MACD(12,26)
Bearish
-3.34
ADX(14)
Strong Trend
40.07
UO(9)
Bearish
52.68
ROC(12)
Uptrend But Slowing Down
3.98
WillR(14)
Neutral
-42.41
Bearish
4
Neutral
4
Bullish
1

About Laurus Labs

Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company based in India. It operates in four business lines: Generics - APIs, Generics - FDFs, Synthesis, and Ingredients. The company specializes in active pharmaceutical ingredients (APIs) for anti-retrovirals, Hepatitis C, and Oncology, among other therapeutic areas. Laurus Labs...more
Listing Date
19 Dec, 2016(9 Years, 6 Months, 20 Days)
Website
https://www.lauruslabs.com
Chairperson NameRavindranath Kancherla
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104